Results 101 to 110 of about 560,455 (319)

The Family Tree : 1940, March

open access: yes, 1940
Vol. 4 No.
Potlatch Forests, Inc.
core  

Data‐Driven SuStaIn Model of Disability Progression in Amyotrophic Lateral Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether ordinal Subtype and Stage Inference (SuStaIn) applied to routine ALSFRS‐R item scores can identify reproducible disability progression patterns in amyotrophic lateral sclerosis (ALS) and provide clinically meaningful staging.
Giammarco Milella   +5 more
wiley   +1 more source

Impact of different Eucalypt species on forest soil properties in Guilan province [PDF]

open access: yesتحقیقات جنگل و صنوبر ایران, 2010
The aim of this study was to investigate the positive or negative effects of eucalypt plantation on different soil properties. For this reason, an eucalypt trial consisting of six species: E. camaldulensis, E. macarthurii, E. maidenii, E.
Hosayn Sardabi   +4 more
doaj  

The Family Tree : 1952, June

open access: yes, 1952
Vol. 16 No.
Potlatch Forests, Inc.
core  

Clinical Impact of MGMT Promoter Methylation in IDH‐Mutant Gliomas: Influence of Threshold Selection and Clinical Confounding

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang   +7 more
wiley   +1 more source

The Family Tree : 1947, December

open access: yes, 1947
Vol. 12 No.
Potlatch Forests, Inc.
core  

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong   +10 more
wiley   +1 more source

Extraction and determination of flavonoid compounds kaempferol and quercetin in petals of Rosa damascene Mill. from North and North eastern Regions of Iran [PDF]

open access: yesفیزیولوژی محیطی گیاهی, 2008
Flavonoid components are the largest phenolic groups in nature. Kaempferol, quercetin has medicinal effects againts viruses and cancer cells. In f this research for extraction and determination of flavonoid compounds kaempferol and Quercetin in petals of
Jaimand, K   +4 more
doaj  

The Family Tree : 1936, October

open access: yes, 1936
Vol. 1 No.
Potlatch Forests, Inc.
core  

Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Elena Badillo Goicoechea   +53 more
wiley   +1 more source

Home - About - Disclaimer - Privacy